INSIGHTS ON CLINICAL TRIAL DESIGN
-
![2020 Onsite eye exam]( "The Implications Of Semaglutide's Connect To Increased Risk Of NAION")
The Implications Of Semaglutide's Connect To Increased Risk Of NAIONExplore the implications of a connection between semaglutide and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION).
-
![Question-marks-GettyImages-1055509894]( "Avoiding Vaporware – Even More Questions To Ask eClinical Platform Providers")
Avoiding Vaporware – Even More Questions To Ask eClinical Platform ProvidersFor a platform that aligns with the demands of modern clinical research, delve into these considerations to ensure your choice supports your study’s success.
-
![GettyImages-879831370_cells lab]( "Podcast―Nonclinical Considerations When Developing Ophthalmic Drugs")
Podcast―Nonclinical Considerations When Developing Ophthalmic DrugsGlobally recognized consultants discuss how they are addressing the most pressing drug development topics in the ocular field.
-
![medidata screenshot]( "The True Science Behind eCOA, Shaped By Patient And Site Insights")
The True Science Behind eCOA, Shaped By Patient And Site InsightsThis webinar brings together patients, sites, and eCOA science to dismantle the researcher-subject hierarchy and replace it with a collaborative model.
-
The Psychedelic Setback: What MDMA Rejection Taught Drug Developers6/25/2026
Psychedelic compounds show real promise for PTSD, but proving it requires solving unblinding, bias, and safety gaps in trial design.
-
Use Data For Fit-For-Purpose Patient Recruitment Strategy10/29/2025
Learn how a proactive, data-integrated approach can transform patient recruitment from a reactive hurdle into a built-in advantage — accelerating enrollment, improving representativeness, and setting studies up for success from day one.
-
How In-Home Trials Can Shift The Pediatric Rare Disease Research Landscape1/6/2026
DCT solutions are not just about bringing the trial to the patient’s home and reducing logistical burdens, but also strengthening the family-researcher connection.
-
Does 'The Belmont Report' Provide Guidance For Patient Stipends?12/5/2025
Consider implementing fair and flexible stipend models that account for individual burdens to enhance diversity, equity, and participation in clinical trials.
-
Stop Guessing On Trial Feasibility: Simulating Patient Recruitment With AI5/28/2026
Simulate enrollment, endpoints, and criteria with integrated data and synthetic populations to test protocol feasibility early — refining design and reducing recruitment and regulatory risks.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-165180340-digital-recruitment-people-patients]( "Accelerate Post-Approval Research By Streamlining the Entire Study Lifecycle")
Streamline post-approval research by embedding studies into routine clinical care. Reduce site burden and capture high-quality data for label expansion and regulatory needs.
-
![Brain]( "Trialtrove: The Most Trusted, Comprehensive & Reliable Clinical Trial Intelligence")
Trialtrove is the industry's go-to resource to support and inform clinical trial strategy, design and execution. Our expert analysts provide insights into trial timing benchmarks, enrollment successes and failures, accrual details and study results.
-
![GettyImages-1135573728-digital-patient-tablet-recruitment]( "Enhance Clinical Trial Screening And Improve Patient Matching Accuracy")
Bridge the gap between raw data and clinical enrollment. Use AI-driven insights and natural language summaries to identify the right patients faster and with greater transparency.
-
TrialScope Disclose delivers the proven solutions clinical trial sponsors need to centralize, track, register, and comply with clinical trial disclosure processes, mitigating compliance risks while giving them greater control over their own clinical trial disclosure reputation.
-
![GettyImages-1403159350 patient experience]( "Educate, Engage, Enroll: Accelerating Patient Recruitment")
Built on a globally compliant platform, explore a suite of technologies and services that sits at the crossroads of sponsors, recruitment partners, patients, HCPs, and trial sites.
